Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10325351 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers
Condition: Herpes Simplex
Interventions: Drug: valacyclovir hydrochloride;   Drug: placebo;   Drug: valacyclovir plus aspirin

Indicates status has not been verified in more than two years